Who to call at Neurogene Inc., and when
Fundz watches for the moments Neurogene Inc. starts buying, and tells you who to reach.
- An alert the day Neurogene Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurogene Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurogene Inc.. With Fundz connected, it knows.
Neurogene Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
neurogene.comAI Executive Summary
AI-powered analysis of 8-K filing content
Neurogene Inc. expanded its Board of Directors to seven members and appointed Christine Mikail, its current President and Chief Financial Officer, as a Class II director effective April 20, 2026, with her term expiring at the 2028 annual stockholders' meeting. The move adds an executive to the board and fills the newly created seat.
Key Takeaways
The Board expanded to seven members to create a new seat, which Christine Mikail fills.
Mikail is a Class II director with her term expiring at the 2028 annual stockholders' meeting.
2 more takeaways
Related Filings (4)
4 more filings from Neurogene Inc. in the last 90 days
Filing Overview
What This Means
Neurogene Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.